| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | CEO | Director +1 more
3 companies
Scott Tarriff last filed a Form 4 in February 2024, as 10% Owner at EGRX. The filings on record cover 3 companies. From March 2015 to February 2024, the filings on record show 0 open-market purchases and 18 sales. Scott Tarriff's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 460,621 shares of EGRX. The EGRX filings lean toward selling, a net 512,597 shares.
Shares as reported in the last Form 4 for each company; the most recent is from February 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 18,360 | $68.08 | $1,249,974.34 | -1.3% | |
| Jan 4, 2016 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 14,549 | $85.91 | $1,249,920.86 | -1.0% | |
| Dec 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 14,050 | $88.93 | $1,249,418.92 | -1.0% | |
| Nov 2, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 19,339 | $64.63 | $1,249,954.91 | -1.3% | |
| Oct 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 17,878 | $69.92 | $1,249,964.73 | -1.2% | |
| Sep 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 16,245 | $76.95 | $1,249,998.04 | -1.1% | |
| Aug 3, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 13,000 | $96.19 | $1,250,408.26 | -0.8% | |
| Jul 1, 2015 | EGRX Eagle Pharmaceuticals, Inc. | President and CEO | Sell | 135,710 | $46.34 | $6,288,854.74 | -8.1% |